MoneyWorks4Me

SMS Lifesciences - Quaterly Results

09 Aug 2022 Evaluate
The revenue for the June 2022 quarter is pegged at Rs. 804.53 millions, about 9.87% up against Rs. 732.25 millions recorded during the year-ago period.An average growth of 41.72% was recorded for the quarter ended June 2022 to Rs. 41.07  millions from Rs. 28.98 millions.OP of the company witnessed a marginal growth to 91.97 millions from 71.44 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 804.53 732.25 9.87 804.53 732.25 9.87 3456.28 2602.56 32.80
Other Income 3.00 0.44 581.82 3.00 0.44 581.82 15.36 13.33 15.23
PBIDT 91.97 71.44 28.74 91.97 71.44 28.74 329.00 310.68 5.90
Interest 11.81 10.69 10.48 11.81 10.69 10.48 46.25 45.00 2.78
PBDT 80.16 60.75 31.95 80.16 60.75 31.95 409.67 265.68 54.20
Depreciation 19.89 19.67 1.12 19.89 19.67 1.12 79.90 72.13 10.77
PBT 60.27 41.08 46.71 60.27 41.08 46.71 329.77 193.55 70.38
TAX 19.20 12.10 58.68 19.20 12.10 58.68 75.96 61.86 22.79
Deferred Tax -0.80 -0.10 700.00 -0.80 -0.10 700.00 0.36 11.59 -96.89
PAT 41.07 28.98 41.72 41.07 28.98 41.72 253.81 131.69 92.73
Equity 30.23 30.23 0.00 30.23 30.23 0.00 30.23 30.23 0.00
PBIDTM(%) 11.43 9.76 17.17 11.43 9.76 17.17 9.52 11.94 -20.26
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..